What the company does
EXACT Therapeutics AS, a clinical stage biopharmaceutical company, develops a novel ultrasound-mediated technology platform for targeted therapeutic enhancement, Acoustic Cluster Therapy (ACT) in Norway. The ACT is an approach to ultrasound-mediated, targeted drug enhancement with the potential to amplify the clinical utility of a range of therapeutic agents across various applications, including oncology, neurological conditions, and gene therapy. The company's ACT platform is under Phase 2 clinical trial for the treatment of pancreatic disease; Phase I clinical trial for treatment of liver metastases; and pre-clinical studies for glioblastoma, and immunotherapy diseases, as well as CNS …
What the weekly tape is saying
EXTX closed the latest completed week at 0.84 NOK. The 4-week return is -34.5% and the 12-week return is -62.9%. Trend Signal is inactive, Market Dynamics is -0.69. Setup signature: Risk-first tape with a 11/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 1.62 NOK
- Vs Trend Line
- -47.9%
- Fair Value
- 5.87 NOK
- Vs Fair Value
- -85.6%
- 52W High
- 3.00 NOK
- 52W Low
- 0.58 NOK
- Drawdown
- -71.8%
- Range Position
- 11.0%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 0
- 52W Active Breadth
- 0.0%
- Sector Scope
- NO Healthcare
- Sector Rank
- 2 of 24
- Sector Percentile
- 95.7%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
NO Healthcare
- Tracked Peers
- 24
- 4W Rank
- 24 of 24
- Avg 1W
- -0.2%
- Avg 4W
- -3.9%
- Trend Breadth
- 33.3%
- Positive MD
- 50.0%
NO Biotechnology
- Tracked Peers
- 11
- 4W Rank
- 11 of 11
- Avg 1W
- -2.2%
- Avg 4W
- -8.1%
- Trend Breadth
- 36.4%
- Positive RS
- 36.4%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.69
- 4W MD Change
- -5.8%
- Relative Strength
- -62.21
- 4W RS Change
- -31.1%
- Expectation
- Negative
- Probability
- 36.71%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 290.0K
- 13W Average
- 437.0K
- 52W Average
- 221.4K
- Vs 13W
- 0.7x
- Vs 52W
- 1.3x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 13.8%
- 52W Volatility
- 16.2%
- Upside Weeks
- 23
- Downside Weeks
- 26
- Downside Breadth
- 50.0%
- Avg Gain / Loss
- 11.5% / -12.4%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- OSL
- Country
- NO
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- NOK
- Market Cap
- 97.0M
Opportunity signals
- Latest weekly return ranks in the strongest part of its sector group.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 0.84 NOK | 11.9% | 1.62 NOK | 5.87 NOK | -0.69 | -62.21 | 290.0K | Off |
| 5 Jun 2026 | 0.76 NOK | -13.2% | 1.65 NOK | 5.94 NOK | -0.50 | -67.16 | 938.8K | Off |
| 29 May 2026 | 0.87 NOK | -40.8% | 1.67 NOK | 6.01 NOK | -0.49 | -62.92 | 704.0K | Off |
| 22 May 2026 | 1.47 NOK | 14.0% | 1.69 NOK | 6.08 NOK | -0.53 | -40.01 | 441.0K | Off |
| 15 May 2026 | 1.29 NOK | -6.5% | 1.72 NOK | 6.14 NOK | -0.65 | -47.46 | 759.4K | Off |
| 8 May 2026 | 1.38 NOK | -4.2% | 1.74 NOK | 6.21 NOK | -0.60 | -43.63 | 233.0K | Off |
| 1 May 2026 | 1.44 NOK | 1.4% | 1.76 NOK | 6.27 NOK | -0.41 | -43.49 | 105.7K | Off |
| 24 Apr 2026 | 1.42 NOK | -7.2% | 1.77 NOK | 6.34 NOK | -0.07 | -44.66 | 174.3K | Off |
| 17 Apr 2026 | 1.53 NOK | -3.2% | 1.80 NOK | 6.42 NOK | 0.36 | -40.77 | 824.4K | Off |
| 10 Apr 2026 | 1.58 NOK | -1.3% | 1.82 NOK | 6.51 NOK | 0.68 | -42.19 | 249.7K | Off |
| 3 Apr 2026 | 1.60 NOK | -8.6% | 1.84 NOK | 6.59 NOK | 0.90 | -42.88 | 528.9K | Off |
| 27 Mar 2026 | 1.75 NOK | -23.2% | 1.87 NOK | 6.67 NOK | 0.97 | -36.55 | 301.5K | Off |
| 20 Mar 2026 | 2.28 NOK | 3.6% | 1.89 NOK | 6.75 NOK | 0.75 | -18.08 | 130.0K | Off |
| 13 Mar 2026 | 2.20 NOK | 26.4% | 1.89 NOK | 6.83 NOK | 0.58 | -21.25 | 99.9K | Off |